Latest Insider Transactions at Aim Immuno Tech Inc. (AIM)
This section provides a real-time view of insider transactions for Aim Immuno Tech Inc. (AIM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AIM ImmunoTech Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AIM ImmunoTech Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2022
|
Stewart Appelrouth Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,500
+15.23%
|
$24,500
$1.07 P/Share
|
|
Apr 25
2022
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
49,020
+12.29%
|
$49,020
$1.02 P/Share
|
|
Apr 25
2022
|
Iii Peter W. Rodino COO, Secretary, Gen. Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,902
+7.2%
|
$4,902
$1.02 P/Share
|
|
Dec 13
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
21,552
+6.69%
|
$21,552
$1.16 P/Share
|
|
Dec 10
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
11,811
+4.06%
|
$11,811
$1.27 P/Share
|
|
Nov 24
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
11,627
+4.17%
|
$11,627
$1.29 P/Share
|
|
Nov 24
2021
|
Stewart Appelrouth Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,379
+14.76%
|
$19,379
$1.29 P/Share
|
|
Nov 23
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
11,194
+4.19%
|
$11,194
$1.34 P/Share
|
|
Nov 19
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
10,204
+4.0%
|
$10,204
$1.47 P/Share
|
|
Nov 17
2021
|
Thomas K Equels CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
9,146
+3.76%
|
$9,146
$1.64 P/Share
|
|
Jul 16
2021
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
15,625
+6.49%
|
$15,625
$1.92 P/Share
|
|
Feb 25
2021
|
Stewart Appelrouth Director |
BUY
Open market or private purchase
|
Direct |
10,638
+10.31%
|
$21,276
$2.35 P/Share
|
|
Feb 24
2021
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
11,062
+5.01%
|
$22,124
$2.26 P/Share
|
|
Dec 17
2020
|
Thomas K Equels CEO & President |
BUY
Open market or private purchase
|
Direct |
14,535
+6.82%
|
$14,535
$1.72 P/Share
|